Latest news
FDA Approves Ardelyx's Kidney Disease-Related Drug
2023-10-27
The U.S. Food and Drug Administration (FDA) has approved Ardelyx's drug to treat high phosphate levels in patients with chronic kidney disease (CKD), the company said on Tuesday, more than two years after it was initially rejected.
Drug-delivery technique for brain cancer shows growing promise
2023-10-18
A technique developed by University of Texas at Dallas and UT Southwestern Medical Center researchers to deliver medication through the blood-brain barrier has shown promise in a preclinical study for treating glioblastoma, the most common human brain cancer.
Gut Microbiome Variations May Be Predictive of Precancerous Colonic Lesions, CRC
2023-10-16
People with precancerous colonic lesions show significant differences in their gut microbiome compared to the general population up to 5 years before the lesions develop, according to a large, 22-year analysis from the Dutch Microbiome Project cohort study.
2023-09-19
NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has granted marketing authorization for LITFULO™ (ritlecitinib) to treat adults and adolescents 12 years of age and older with severe alopecia areata.
Science Wins Infinite Future
Research